ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
AM181176.4|Pseudomonas_1 # 1 # 1377 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.659	AM181176.4|Pseudomonas_1 	1	1377	-	Loose	400	229.95	TxR	41.53	3005008	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAGTATCGATAACCAGATTCAGGTGGTGTTGATCGACGACGATCCACACCTGCGTCAGGCCTTGTGCCAGACCCTGGACCTGGCCGGGCTGAAAGTCCTGACCCTGGGCGAAGCCACCGGCCTCACCGCGCGCTTGTCGCGGGACTGGCCAGGCGTGGTGGTCAGCGACATCCGCATGCCCGGCATGGACGGTCTGGAGTTGCTGGCAGAACTGCACGGCCAGGACCCGGACCTGCCGGTGCTGCTGATCACCGGCCACGGCGACGTGCCGCTGGCGGTGCAGGCCATGCGCGCCGGCGCCTATGATTTCCTGGAAAAGCCGTTCGCCAGCGACGCCCTGCTCGACAGCGTGCGTCGCGCCCTCGCCCTGCGCCGCCTGGTGCTGGACAACCGCAGCCTGCGCCTGGCCCTCAGCGACCGCCAGCAACTGAGCACGCGCCTGGTGGGGCACTCCCCGCAAATGCTGCGCCTGCGCGAACAGATCGGCGCGTTGGCCGCGACCAAGGCCGATGTGCTGATTCTCGGCGAAACCGGCGCCGGCAAAGAGGTGGTCGCCCGCGCACTGCACGACCTGTCCAGTCGTCGTAGCGGCCCCTTTGTGGCGATCAACGCCGGGGCGTTGGCCGAATCGGTCGTCGAAAGCGAGCTGTTCGGCCATGAGCCCGGCGCCTTTACCGGCGCGCAGAAGCGCCGTATCGGCAAGTTCGAATTCGCCAACGGCGGCACCTTGTTCCTCGATGAAATTGAAAGCATGAGCCTGGATGTACAGGTCAAACTCTTGCGCCTGTTGCAGGAGCGCGTGGTGGAGCGCCTGGGCGGCAATCAGTTGATCCCGCTGGATATCCGCATCATCGCCGCGACCAAGGAAGACCTGCGCCAGTCCGCCGACCAGGGCCGCTTCCGTGCCGACTTGTATTACCGCCTCAACGTCGCGCCGCTGCGCATTCCGCCACTGCGTGAGCGCGGTGAAGATGCACTGATGTTGTTCCAGCACTTCGCCGATGAAGCCAGCAGCCGCCACGGCCTGCCACTGCATGAGCTGCAACCGGGGCAGCGCGCGCTGCTGTTGCGCCATAGCTGGCCGGGCAACGTACGTGAATTGCAGAACGCCGCCGAACGCTTCGCGCTGGGCCTGGAACTGGCGCTGGACAGCTCGCCGGACAACCCAGCGGCTGGCGTCCTGACCTCCACACCCGGCGGCCTGAGCGAGCAAGTCGAGCAGTTCGAAAAGAGCCTGATCGCTGCCGAACTGACTCGCCCCCACGGTTCCATGCGCAGCCTCGCCGAAGCCCTGGGCGTACCGCGCAAGACACTGCACGACAAACTGCGCAAGCACGGCCTGAATTTCGCCAACCAAAGTGGCGACGACGAATGA	MSIDNQIQVVLIDDDPHLRQALCQTLDLAGLKVLTLGEATGLTARLSRDWPGVVVSDIRMPGMDGLELLAELHGQDPDLPVLLITGHGDVPLAVQAMRAGAYDFLEKPFASDALLDSVRRALALRRLVLDNRSLRLALSDRQQLSTRLVGHSPQMLRLREQIGALAATKADVLILGETGAGKEVVARALHDLSSRRSGPFVAINAGALAESVVESELFGHEPGAFTGAQKRRIGKFEFANGGTLFLDEIESMSLDVQVKLLRLLQERVVERLGGNQLIPLDIRIIAATKEDLRQSADQGRFRADLYYRLNVAPLRIPPLRERGEDALMLFQHFADEASSRHGLPLHELQPGQRALLLRHSWPGNVRELQNAAERFALGLELALDSSPDNPAAGVLTSTPGGLSEQVEQFEKSLIAAELTRPHGSMRSLAEALGVPRKTLHDKLRKHGLNFANQSGDDE	MKVQKCKATIHRRSLDADPLLPLIGNSTCISELRNKLKKYAQCDAEVLIQGETGVGKGMCARIIHELSSRHIYPFVEVNCGAIPSGLIASELFGHEKGAFTGAISDRIGFIQKANKGTLFLDEIGDMPPDLQIHLLHFLESKQIHKVGADKIIDVDCRVIAASHVDLKSEVIQGGFREDLFYRQNILPLTIPPLRKRGEDTVILSERFLEELSNGKVQSMSPEVKKKLLKHKWPGNVRELRNVIQRAIVMCEDNTLHIADLGLDNNERQLLPSVEQIDLDYLLKAIEDNKHNMSAAARNLGISRTTLYRLIKKYNLPI	144.03	gnl|BL_ORD_ID|4724|hsp_num:0	3753			66	948	tetracycline
AM181176.4|Pseudomonas_2 # 1374 # 3191 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.655	AM181176.4|Pseudomonas_2 	1374	3191	-	Loose	850	68.5514	baeS	30.45	3000829	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTCCCATGACCCCATCCCTCCCGCGTAGACCCCGCTGGCGCAGCCTCGCCCTGCTGGCGTTGTGCTTGGCACCGCTGCTGTGGCCACTGGAGCACCTGGCTGAGCGTTATTACCGCAGCGAGCTGGCGGGGCAGAATCGTCAGACCCTCGATCTGTACGTGGCCAACCTGCTCGGCACCCTGCACCGCTATGAAGTGTTGCCGCAGATCCTCGGCGACCTGCCGGCCCTGCGCACAGCGCTGGATGCGCCCCAAGTCAGCACCAACCTGGTCAACGCCAACCTGCTGCTCAAGGACGTCGCCGCCCAGGCCGGAGTGGAAGTGATGTACCTGATGGACACCCGCGGCAAGACCCTCGCCGCGTCCAATTGGGATAAACAGGACAGCTTTGTCGGGCGCAACTTCTCGTTCCGCCCCTACTTCAGCGAAGCCATGGACGGACGCCTGGGGCGCTTTTTCGGCCTGGGCACCACCTCGGCCAAACGCGGTTACTTCTTTGCCGCCGCCGTGCGTGATGGCGAGAAAATCATCGGTGTGCTGGTGGTCAAGGTGGACCTGGACCACACCGAAAGCCTGTGGGGCAACACCCCGGAACAGCTCTTGGTGACCGACCATAACGGCGTGGTCATCCTGACGTCGCGCCCGCAATGGCGATTCCGCGCCACCCGGCCGCTGACCGCCGCAGAGCGCCAGGCCATCATCGCCATCCAGCCCTACCCGACCCGCGATCCGCAGCCGCTGAGCCTGAGCAGCACCGCTTGGCTGCGTCAATCCACGGCCATCGCCGAGACGGGCTGGAACGTGGAGATCCTCGCGCCGCGCTCGCTGATCAACCGGCCGGTGCGTACAGTCGTTGCGGTGGGCGGCGCCACGCTCTTGGTCTTGATGTTGCTGCTGGGGTTGATGATGCAACGCCGCCGCCATTACCTGGAACGCATTGCCTTTGAAGCCAAGGCCCGTCGCGAGCTGGAAGCGCGCGTGGTCGAGCGGACCAGCGACCTGGAAGGCCTCAACCGTCGCCTGAAACAGGAAGTGCTGGAACGCGAACACGCCCAGCAGGAATTGGTGCGCGCCCAGGATGACCTGGTGCAGGCGGGCAAACTGTCGGCATTGGGCACCATGTCGGCGAGCATCAGCCATGAACTCAACCAACCCCTGGCGGCGATTCGCAGCTACGCGGAAAACGCCGAGATCCTGCTCGACCATGAGCGCACCACTGATGCGCGCGGCAATCTCAAGCTGATCAGCGAACTGACCGGGCGCATGGCCTCGATCATCGCCCACCTGCGCGCCTTTGCCCGCCGCGACCGCCATGCGCCAGAGAGCGTGGCCCTGCAACCGGCGCTGGACGATGCGCTGGCGTTGCTGGCCAAGCGGCGGCGGTCGATGGAGGTGGAGCTGATCCGCGACTTGCCGGAAGCGACCCTGTGGGTGCAAGCCGGCGAAACCCGCCTGCGACAGGTGCTCGGCAACCTGCTGGCCAATGCCCTCGACGCCCTCACCGAAAAAGGCCCGCCGCGCAAACTGTGGCTGAGTGCCGAAACCACCGAACAGGGCGTCAACCTGTACATTCGCGACAACGGCCCGGGCTTTTGCATGGAGGCCCTGGGCCGCGCCAGCGAGCCGTTCTATACCACCAAGACACGCACCCAGGGCCTGGGCTTGGGCCTGGCGATCTGTGACACCCTGATGCGTGCCTTTGGCGGCGAACTGCTGTTCGCCAACCACAAGGAAGGCGGCGCGCTGTTAACCTTGAAATTGCGTGCCGGCTCGCCGGGCGTCAGTCTGCAACCGTCCGAGGACCGCAGTGTATGA	MTPMTPSLPRRPRWRSLALLALCLAPLLWPLEHLAERYYRSELAGQNRQTLDLYVANLLGTLHRYEVLPQILGDLPALRTALDAPQVSTNLVNANLLLKDVAAQAGVEVMYLMDTRGKTLAASNWDKQDSFVGRNFSFRPYFSEAMDGRLGRFFGLGTTSAKRGYFFAAAVRDGEKIIGVLVVKVDLDHTESLWGNTPEQLLVTDHNGVVILTSRPQWRFRATRPLTAAERQAIIAIQPYPTRDPQPLSLSSTAWLRQSTAIAETGWNVEILAPRSLINRPVRTVVAVGGATLLVLMLLLGLMMQRRRHYLERIAFEAKARRELEARVVERTSDLEGLNRRLKQEVLEREHAQQELVRAQDDLVQAGKLSALGTMSASISHELNQPLAAIRSYAENAEILLDHERTTDARGNLKLISELTGRMASIIAHLRAFARRDRHAPESVALQPALDDALALLAKRRRSMEVELIRDLPEATLWVQAGETRLRQVLGNLLANALDALTEKGPPRKLWLSAETTEQGVNLYIRDNGPGFCMEALGRASEPFYTTKTRTQGLGLGLAICDTLMRAFGGELLFANHKEGGALLTLKLRAGSPGVSLQPSEDRSV	MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGEQYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAALATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV	129.55	gnl|BL_ORD_ID|913|hsp_num:0	986			735	1371	novobiocin
AM181176.4|Pseudomonas_3 # 3219 # 4088 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.644	AM181176.4|Pseudomonas_3 	3219	4088	-	Loose	1500	27.7202	kdpD	29.69	3004047	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	ATGAAGGTCTTGATCACCGGCCAACACGGCCAAGTCTCCCGAGAACTGCAACTGCAGCTCCAAGGCCTGGGCGAGCTCATCGTCCTGGGCCGCGACCAGCTTGACCTGGCCAACGCCGACCAGATCCGCCAGCAAATCCGGGCCCATCGCCCCGACCTGATCATCAACGCCGCAGCCCACACTGCCGTCGATCAAGCCGAAAGCGAGCCGGACGCGGCCTTCGCGATCAACGCAATTGCTCCTGGTGTTCTCGCAGAAGAAGCCAAGGCACTGGGCATCCCGTTGATCCACTACTCCACCGACTACGTGTTCGACGGCAGCAAGCCGGACCCCTATACCGAAGCCGACACGCCGAACCCGCTGGGTGTCTACGGCCAGAGCAAACTGGCGGGCGAGGAGGCGATTGCGGCCGTGGGCGGCGACTACCTGATCCTGCGCACCAGTTGGGTCTATTCCAGCCATGGCAAGAATTTCCTGCTGACCATGCAGCGCCTGCTGCAGGAGAAACCGCAGATGCGCATCGTCGCCGACCAGATCGGCGCGCCGACGTGGGCTGGCAGCATCGCGCGCAGCACGCGTGCGCTGATCGAGCGCTGGCAAGCGGGCGAACCGGGAGAATGGGGTATCTACCACCTGACCAACCAAGGTGAGACCTCGTGGTTCGGTTTTGCCGAGGCCATCGGCGCGCATCTGCGCACGCAGGGCAAAGCGTGCGCCGAACTGGAAGCGATCCCTTCCAGTGCCTACCCGACGCCAGCCAAGCGCCCCTTGAACTCGCGCCTTGACTGCAGCCGCCTGCAGCAGCAATGGCACGTCAGCCAGCCGAGCTGGCAAGACGCATTGCGCGAGTGTCTTGCACAGCCGCACTAG	MKVLITGQHGQVSRELQLQLQGLGELIVLGRDQLDLANADQIRQQIRAHRPDLIINAAAHTAVDQAESEPDAAFAINAIAPGVLAEEAKALGIPLIHYSTDYVFDGSKPDPYTEADTPNPLGVYGQSKLAGEEAIAAVGGDYLILRTSWVYSSHGKNFLLTMQRLLQEKPQMRIVADQIGAPTWAGSIARSTRALIERWQAGEPGEWGIYHLTNQGETSWFGFAEAIGAHLRTQGKACAELEAIPSSAYPTPAKRPLNSRLDCSRLQQQWHVSQPSWQDALRECLAQPH	MSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNIDIKIGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIKESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYTHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITVYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVSLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI	32.66	gnl|BL_ORD_ID|4924|hsp_num:0	5918			2325	2517	kanamycin A
AM181176.4|Pseudomonas_4 # 4085 # 4609 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=GAAT;rbs_spacer=15bp;gc_cont=0.554	AM181176.4|Pseudomonas_4 	4085	4609	-	Loose	700	25.409	ACT-42	24.14	3006237	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	TTGCCCGGTGTACTGATCATCGAGCCGAAGGTTTTTGGCGATGAACGCGGTTTTTTCTATGAGAGCTACAACGCCCGGAATTTCGCACAAGCCACTGGTCAGCACGTGGATTTTGTCCAGGACAACCACTCGCGTTCGCAAAAAGGCGTCTTGCGCGGTTTGCACTACCAGATCGAACACGCTCAGGGAAAACTGGTGCGTGTCACAGCGGGTGAAGTCCTGGACGTAGCGGTGGACATCCGCCGCAGCTCACCGCATTTTGGCAAATGGGCCAGCGTGCGCTTGTCTGCCGAAAACAGCCGTCAACTGTGGATTCCGCCGGGGTTTGCCCATGGTTTTGTCGTGCTCAGTGACTCTGCTGAATTCCTCTACAAAACCACCGATTACTACACGCCCTCTGCGGAACGCTGCATTCGCTGGGACGATGCTGATCTGGATATCGATTGGCAGTTTGCCGGTACCCCGACGCTGTCCGGCAAGGATCAAAACGGCAAGAGCCTGAAAGAGGCAGACCTTTTCCCATGA	MPGVLIIEPKVFGDERGFFYESYNARNFAQATGQHVDFVQDNHSRSQKGVLRGLHYQIEHAQGKLVRVTAGEVLDVAVDIRRSSPHFGKWASVRLSAENSRQLWIPPGFAHGFVVLSDSAEFLYKTTDYYTPSAERCIRWDDADLDIDWQFAGTPTLSGKDQNGKSLKEADLFP	MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTAVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTRINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ	45.67	gnl|BL_ORD_ID|2007|hsp_num:0	4133			612	786	
AM181176.4|Pseudomonas_5 # 4627 # 5502 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.592	AM181176.4|Pseudomonas_5 	4627	5502	-	Loose	200	26.9498	FosX	34.29	3000198	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGATGAAGGGAATCGTATTGGCCGGCGGTTCCGGCACGCGTTTGCACCCCATTACCCTGGGCGTCTCCAAGCAATTGCTGCCGGTGTACGACAAGCCGATGATCTACTACCCGATCTCGGTGCTGATGCTGGCGGGGATCAAAGACATCCTAGTGATTTCCACACCGGTGGACCTGCCGCAATACCGCAACCTGCTGGGGGATGGCAGCCAGTTTGGCGTGCGTTTCAGTTATGCCGAACAGCCGTCGCCCGATGGCTTGGCCCAGGCGTTCCTGATTGGCGAGGAGTTTATCGGCGAAGACCCGGTGTGCCTGATCCTGGGCGACAACATCTTCCACGGCCAGCACTTCGGCGATCAATTGCGCACCGCGGCCGAACGCGCTAGCGGGGCCACGGTATTCGGCTACTGGGTCAAGGACCCGGAGCGTTTTGGCGTGATCGACTTCGACAAGGAAGGCCGTGCCCTGTCCATCGAAGAAAAACCGGCCAAGCCCAAGTCGCCCTATGCGGTCACCGGCCTGTATTTCTACGACAACGACGTGATCAAGATCGCCAAGGACGTTAAGCCTTCGCCCCGTGGGGAGCTTGAGATCACCGACGTCAACAACGCCTACCTCAAGCGTGGCGACCTGCACGTAGAGCGCTTCGGCCGCGGCTTTGCCTGGCTGGACACCGGTACCCATGACAGCCTGCTCGAAGCCTCCACCTATGTGCAGACCATCGAGCATCGCCAGGGCTTGAAAGTCGCCTGCCTGGAAGAAATCGCCTACGAAAATGGCTGGATCGACCGTGACTATCTGCTGGAGCGTGCCAAGTACTTTGGCAAGACCGGCTATGGTCAATATCTTTTCACGCTCGCAGGGGAAACTGCATGA	MMKGIVLAGGSGTRLHPITLGVSKQLLPVYDKPMIYYPISVLMLAGIKDILVISTPVDLPQYRNLLGDGSQFGVRFSYAEQPSPDGLAQAFLIGEEFIGEDPVCLILGDNIFHGQHFGDQLRTAAERASGATVFGYWVKDPERFGVIDFDKEGRALSIEEKPAKPKSPYAVTGLYFYDNDVIKIAKDVKPSPRGELEITDVNNAYLKRGDLHVERFGRGFAWLDTGTHDSLLEASTYVQTIEHRQGLKVACLEEIAYENGWIDRDYLLERAKYFGKTGYGQYLFTLAGETA	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	218.80	gnl|BL_ORD_ID|111|hsp_num:0	129			234	339	fosfomycin
AM181176.4|Pseudomonas_6 # 5499 # 6581 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.611	AM181176.4|Pseudomonas_6 	5499	6581	-	Loose	1200	41.2022	arnA	23.61	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGCATTCTCATCACCGGCGGCGCTGGTTTTATCGGCTCTGCCCTGATCCGCCATTTGATTGAAAACACCGAGCACCAAGTGCTCAACCTGGACAAACTCACCTACGCCGGCAACCTGGAGTCGCTGACCAGCATCGCGTCCGACAGCCGCTATGAGTTCGTCCAGGCCGATATCGTCGACCAGGCCACCGTCAGCGCCGTACTGGCGCGCTTCGAGCCGCAGGCGATCATGCACCTGGCAGCCGAGTCCCATGTCGACCGCTCCATCGACGGCCCGTCGGATTTTATCCAGACCAACATCGTCGGCACCTACAGCTTGCTCGAAGCCACCCGCGCCTATTGGCAGAAGCTCGATGAGCCGGCCAAGCGTGCGTTCCGCTTCCATCACATTTCCACCGACGAGGTGTACGGCGACTTGCATGGTGTGGACGATCTGTTCACAGAAACCACACCCTATGCGCCCAGCTCACCGTACTCGGCCAGCAAGGCGGCGTCCGACCACCTGGTCCGCGCCTGGCAGCGCACCTACGGCCTGCCGGTTTTGCTGACCAACTGTTCGAACAACTACGGGCCGTTCCACTTCCCCGAGAAGCTGATCCCGCTGGTGATCCTCAACGCCCTCGCGGGCAAGCCACTGCCGGTCTACGGTGATGGCTTGCAGGTGCGTGACTGGCTGTTCGTCGAAGACCACGCCCGCGCACTGCTCACAGTAGTCACCGAAGGCGTGGTCGGCGAGACCTACAACATTGGCGGGCACAACGAGCAGAAGAATATCGACGTGGTGCGCGGCATCTGCGCCCTGCTCGAAGAGCTCGCGCCACAGCGCCCGGCCGGGGTCGCGCAATTTGCCGACCTGATCACCTTCGTCAAGGACCGCCCAGGCCACGATCAGCGCTATGCGATCGATGCCAGCAAGATTGAACGCGAACTGGGCTGGGTTCCTGAAGAAACCTTCGAATCCGGTTTGCGCAAGACCGTGCAGTGGTACCTCGATAACCTGGAATGGTGCCGCAGGGTCCAGGACGGCAGTTATCAGGGCGAACGTTTGGGCAACACCGACTTTAAGGATCTGATTGCATGA	MRILITGGAGFIGSALIRHLIENTEHQVLNLDKLTYAGNLESLTSIASDSRYEFVQADIVDQATVSAVLARFEPQAIMHLAAESHVDRSIDGPSDFIQTNIVGTYSLLEATRAYWQKLDEPAKRAFRFHHISTDEVYGDLHGVDDLFTETTPYAPSSPYSASKAASDHLVRAWQRTYGLPVLLTNCSNNYGPFHFPEKLIPLVILNALAGKPLPVYGDGLQVRDWLFVEDHARALLTVVTEGVVGETYNIGGHNEQKNIDVVRGICALLEELAPQRPAGVAQFADLITFVKDRPGHDQRYAIDASKIERELGWVPEETFESGLRKTVQWYLDNLEWCRRVQDGSYQGERLGNTDFKDLIA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	54.38	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1953	polymyxin B
AM181176.4|Pseudomonas_7 # 6733 # 9642 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AAAAA;rbs_spacer=15bp;gc_cont=0.638	AM181176.4|Pseudomonas_7 	6733	9642	+	Loose	550	30.4166	APH(2'')-Ig	43.75	3002669	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGTTGCTCGCCACGTTGATTCATCGCGCCAGCCTGCCTTGCCCACACGTCAGCTCCGACCGGGCCGCACAGTTGCTCGAGCAGCATTACGGCCTCACCGGCACCTTGCAGTCACTGGGTAGCCAGCAAGACCTCAATTATAGAGTCGACAGCGACCGTGGCCGCTTTGTTCTGAAGATCTGCCGGGGTGACTACGCGGCCGTTGAGCTGCAGGCGCAGCACGCGGCGCTGAACAGTCTGAAGGCCGATGCACACGTGCAGGTGCCCGAGGTCATCCAGGCGCTCACCGGTGAAGAGTTGCTCTCCGTCGTGGTGGACGGCCAGACCCTGCATCTGCGGCTGTTGGGGTACATCGACGGCCAGCCGCTGACCCATCAGCCCCATCTGGGCCGTGACGTGATCGCAGGCTTTGGTGAGCTGTGCGGACGCATGAACCTGGCGCTGGCCGATTTCAAGCACCCTGGCCTGGATCGCACCTTGCAGTGGGACCCGCGTCACGCCCAGGCATTGATTGCCCACCTGCTGGCAACGCTTGAAAACCTGCCCCAGCGCGCCGCACTGGAGCAAGCGGCCGAGCAGGTAGCGACGCGCCTGCACGCCGTGGCCGACCGCCTGCCGTGGCAAGCGGTGCACATGGACATCACCGACGACAACGTCGTGTGGCAGCGTGATGCGCAGCGGCATTGGCAGGTCCGGGGCGTGATCGATTTCGGCGACCTGGTGCACACCTGGCGCATTGCCGACCTATCGGTCACCTGCGCCGCCCTGTTGCATCACGCTGAGGGCGATCCCTTTGCGATCTTGCCGGCGATCCAGGCCTGTCACGCGGTGACACCGTTAGAGCCGGCAGAATTGCAGGCGCTGTGGCCGCTGATCGTCGCCCGTGCGGCGGTGCTGGTCTTGAGCAGCGAGCAACAGCAGCGCCTGGACCCGGATAACACTTACCTGTTGAAAAACGCCGAGCATGAGTGGGAAATTTTCCATGTGGCGACGTCAGTGCCGTTTGAGCTGATGGAGGCGGCGATTCTAAGCAGCGTCGGGCAGGCACCGGCACCGATCGACGGGCAAGGCTTCGCGCCTTTGCTGCCGGGGCTGGTCGGGCGCGAGTTCGCGCTGATCGACCTGGGTGTACTCAGCCCGCATTTCGACGCCGGGAATTGGGAGCAACCCGGTATCGATCAGCGTTTGTTGCAGGATGCGGCGGTGGTGCACGGCCTGGCCGCGAGTCGCTATGGGCAATACCGTTTGTCGCGTACCCAGCCGGACAGCGCCCACGAGCCCGAGACCTTCCCGTTGCACGTCGAATTACAGGTGCCTCAGGGGACTGCCGTTGAAGCGCCGTTCGCCGGCATTGTGCGATCGGGTGTCAATGGCGAACTCCAGGTGCACAGCAACGCGGTAAACGTACGACTGTGGGGCGTAAAAGCGCTGGTTCAGCCGGGTGGGGCGGTGCTCAAGGGCCAGGTGATCGGTGCGGTTGAAGGCCCGCTGACCGTGCAACTCTGTCGCACTGACGGGCCCGCACCGCTGTTTTGCACGCCTTCCCGCGCGCAGGCCTGGCAAACGCTGTGCCCTTCACCCGCAGCGGTGCTGGGATTGGCCTGCGACGCCGAACCCGAGTTGGACCCCGAGGCCCTGCTGGCCCGCCGCGACGCCAGTTTCGCCCGTTCGCAAAAGCACTATTACGTCGACCCGCCGCGCATCGAGCGCGGCTGGCGCAATCACTTGATCGATATGCAGGGCCGTTCCTACCTGGACATGCTCAACAACGTGGCCGTGCTGGGCCACGGTCACCCGCGCATGGCGGCGGTGGCGGCGCGGCAATGGTCATTGCTCAACACCAACTCGCGCTTTCACTACGCGGCGATTGCCGAGTTTTCCGAACGTTTGCTGGCGCTGGCACCGGAAGGCATGGACCGGGTGTTCCTGGTCAACAGTGGTACCGAAGCCAATGACCTGGCGATCCGCCTGGCCTGGGCCTACAGCGGCGGGCGCGACATGCTCAGCGTGCTGGAGGCTTACCACGGCTGGTCGGTGGCGGCGGATGCAGTGTCCACGTCGATTGCCGACAACCCCAAGGCCTTGAGCAGCCGCCCGGATTGGGTGCACCCGGTGACGGCGCCCAACACCTATCGCGGTGAGTTCCGTGGGCAGGACAGCGCGCCCGATTACGTCAGAAGCGTGGAGCACAACCTGGCGAAAATCGCCGCGAGCAAGCGCCCATTGGCGGGCTTTATCTGTGAGCCGGTGTACGGCAATGCCGGTGGTATTTCGTTGCCACCGGGCTATCTGCAGCAGGTGTATGCGCGGGTACGCGCCCAGGGTGGCGTGTGCATCGCCGATGAGGTGCAGGTGGGTTACGGCCGCATGGGGCATTTTTTCTGGGGCTTTGAAGAGCAGGGTGTGGTGCCCGATATCATCACCATGGCCAAGGGCATGGGCAACGGCCAGCCCCTCGGCGCGGTGATTACCCGGCGTGAAATTGCTGAGGCGCTCGAGGCCGAGGGGTATTTCTTCTCGTCGTCGGGAGGCAGCCCGGTGAGTTGCCGGATCGGCATGGCCGTGTTGGATGTGATGCAAGAAGAAAAGCTGTGGGAAAACGCCCAGGTGGTCGGTGGGCATTTCAAGGCGCGGCTGGAAGAACTGATCGATCGCCATCCTCTGGTGGGCGCCGTCCACGGCTCTGGCTTCTATCTGGGCCTCGAGTTGGTGCGCGACCGGCAAACGCTGGAGCCCGCCACCGAAGAAACAACGTTGTTGTGTGACCGCCTGCGGGAGTTGGGGATTTTCATGCAGCCCACCGGTGATTATTTAAACATCCTCAAGATCAAGCCGCCGATGGTCACGTCCCTACGCAGTGTGGACTTCTTCGTCGACATGCTGTCGAAGGTGCTGGATGAGCAGCTGTAA	MLLATLIHRASLPCPHVSSDRAAQLLEQHYGLTGTLQSLGSQQDLNYRVDSDRGRFVLKICRGDYAAVELQAQHAALNSLKADAHVQVPEVIQALTGEELLSVVVDGQTLHLRLLGYIDGQPLTHQPHLGRDVIAGFGELCGRMNLALADFKHPGLDRTLQWDPRHAQALIAHLLATLENLPQRAALEQAAEQVATRLHAVADRLPWQAVHMDITDDNVVWQRDAQRHWQVRGVIDFGDLVHTWRIADLSVTCAALLHHAEGDPFAILPAIQACHAVTPLEPAELQALWPLIVARAAVLVLSSEQQQRLDPDNTYLLKNAEHEWEIFHVATSVPFELMEAAILSSVGQAPAPIDGQGFAPLLPGLVGREFALIDLGVLSPHFDAGNWEQPGIDQRLLQDAAVVHGLAASRYGQYRLSRTQPDSAHEPETFPLHVELQVPQGTAVEAPFAGIVRSGVNGELQVHSNAVNVRLWGVKALVQPGGAVLKGQVIGAVEGPLTVQLCRTDGPAPLFCTPSRAQAWQTLCPSPAAVLGLACDAEPELDPEALLARRDASFARSQKHYYVDPPRIERGWRNHLIDMQGRSYLDMLNNVAVLGHGHPRMAAVAARQWSLLNTNSRFHYAAIAEFSERLLALAPEGMDRVFLVNSGTEANDLAIRLAWAYSGGRDMLSVLEAYHGWSVAADAVSTSIADNPKALSSRPDWVHPVTAPNTYRGEFRGQDSAPDYVRSVEHNLAKIAASKRPLAGFICEPVYGNAGGISLPPGYLQQVYARVRAQGGVCIADEVQVGYGRMGHFFWGFEEQGVVPDIITMAKGMGNGQPLGAVITRREIAEALEAEGYFFSSSGGSPVSCRIGMAVLDVMQEEKLWENAQVVGGHFKARLEELIDRHPLVGAVHGSGFYLGLELVRDRQTLEPATEETTLLCDRLRELGIFMQPTGDYLNILKIKPPMVTSLRSVDFFVDMLSKVLDEQL	MCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRVTQQREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALASDMAIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYEHIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDDFGKDFGRKVLRHYGHRNPQLAERKAEINDAYWPIQQVLLGVQREDRSLFCKGYRELLAIDPDAFIL	316.67	gnl|BL_ORD_ID|831|hsp_num:0	903			585	666	amikacin; kanamycin A; tobramycin; gentamicin A; gentamicin
AM181176.4|Pseudomonas_8 # 9842 # 10870 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.629	AM181176.4|Pseudomonas_8 	9842	10870	+	Loose	750	27.335	tet(X6)	31.82	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGATCTGGCCTGAGCGCCCGGACAACTGGCGCCTGGGCGGCAAGCCGGCGCAGGCCGCTCACGTGGCGGTGGCCAAGGCCATCGCGCGTTTTGAGCCGGTCACCGTGGCGGTTTCCGCCGGCCAGTACGAAAACGCCCGTGCGCGCCTGGATGTGCCGAATATCCGTGTGGTGGAGATGTCCAGTGACGACGCCTGGGTGCGCGACACCGGCCCTACCTTTGTGATCAACCGCAGTGGCGAAGTGCGTGGCGTGAACTGGGACTTCAACGCCTGGGGCGGTTTTGACGGCGGCCTGTATTCGCCGTGGAACCGCGACTCGCAGATCGGCGGCAAGATCCTCGAGATCGAACGCGCCCCGCGCTATTGCACCGAAGGCTTTGTGCTGGAAGGCGGTTCGATCCATGTCGACGGCGAAGGCACCCTGATCACCACCGAAGAATGCCTGCTTAACTCCAATCGCAACCCGCACCTCGACCGTGCACAGATCGAAGCGGTGCTGAGCGCCAATCTGGCGGTGGATAAAATCATCTGGCTGCCGGACGGTCTGTTCAACGACGAAACCGACGGCCACGTGGATAACTTCTGCTGCTACGTGCGTCCAGGTGAAGTGCTGCTGGCCTGGACCGATGACCCGCAAGACCCGAACTACGCACGCTGCCACGCCGCGATGAACGTGCTGCAAAGCAGCACTGACGCCCAGGGTCGCTCGTTCACAGTGCATAAAATGCCGATCCCGGGGCCGCTGTATGCCACCGAGGCAGAGTGCGCCGGTGTAGACCCGGTTGACGGCACCCAGGAGCGTAATCCGACCGTGCGGTTGGCCGGTTCCTACGTCAACTTCCTGATCGTCAACGGTGGCATCATCGCGCCGAGCTTTGATGATCCGCTGGACAGCCAGGCCAAGGCGATCCTGCAGGACCTGTTCCCGCAGCACGAAGTGGTGATGGTGCCCGGCCGCGAACTGTTACTGGGTGGCGGCAATATCCACTGTCTGACCCAACAGCAGCCCGCGCCGCACAAAAATTGA	MIWPERPDNWRLGGKPAQAAHVAVAKAIARFEPVTVAVSAGQYENARARLDVPNIRVVEMSSDDAWVRDTGPTFVINRSGEVRGVNWDFNAWGGFDGGLYSPWNRDSQIGGKILEIERAPRYCTEGFVLEGGSIHVDGEGTLITTEECLLNSNRNPHLDRAQIEAVLSANLAVDKIIWLPDGLFNDETDGHVDNFCCYVRPGEVLLAWTDDPQDPNYARCHAAMNVLQSSTDAQGRSFTVHKMPIPGPLYATEAECAGVDPVDGTQERNPTVRLAGSYVNFLIVNGGIIAPSFDDPLDSQAKAILQDLFPQHEVVMVPGRELLLGGGNIHCLTQQQPAPHKN	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	90.48	gnl|BL_ORD_ID|4802|hsp_num:0	3797			243	375	tetracycline; minocycline; oxytetracycline
AM181176.4|Pseudomonas_9 # 11125 # 11319 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAAT;rbs_spacer=15bp;gc_cont=0.590	AM181176.4|Pseudomonas_9 	11125	11319	+	Loose	725	22.7126	SRT-3	25.37	3006853	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	SRT beta-lactamase	ATGTACACGCGTACGTTCCACCCTTTGCGGGTCGACGGCGACGCGATTCATGCGCTGGCGCTCTGGTTGAAGGAAAACGGCTCGCGGCAGATCCGGCAGCAGCCTGATTGGCGCAGCGTGATGAGTGAACGGTACCCGGTGGGCTTGTTCAGTGAGGACGAAGTGCACGCGTTGTGCGAGTTGATAAACAACTAG	MYTRTFHPLRVDGDAIHALALWLKENGSRQIRQQPDWRSVMSERYPVGLFSEDEVHALCELINN	MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDRPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGVFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYRIVQALDKR	16.93	gnl|BL_ORD_ID|4594|hsp_num:0	5664			651	849	
AM181176.4|Pseudomonas_12 # 15371 # 15727 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.583	AM181176.4|Pseudomonas_12 	15371	15727	+	Loose	400	67.0106	Escherichia coli fabG mutations conferring resistance to triclosan	38.98	3004049	protein variant model	Y151V	n/a	disinfecting agents and antiseptics	antibiotic target alteration	antibiotic resistant fabG	ATGGAAAAGAACAACGCCGGCCGCATCGTCCACATCACCACCAGCCTGGCTGACCATGCAATCGATGGCGTACCGTCGGTACTTGCCAACCTCACCAAAGGCGGCCTGAACTCAGCGCCCAAATCATTGGCGATTGAATACGCCAAGCGCGGTATCCGAGTGAATGCGGTAAGCCCGGGGATCATCAAGACGCCGATGCATGGCGAGGAAAGCCATGCTGCGCTGGGGCAAATGCACCCGGTTGGGCACATGGGGGAGGTGAGTGAAATCGCCCAGGCGATTATTTATCTGGAGAATGCGGGGTTCGTGACGGGGGAGATTCTTCATGTAGACGGCGGGCAGAGTGCCGGGCATTGA	MEKNNAGRIVHITTSLADHAIDGVPSVLANLTKGGLNSAPKSLAIEYAKRGIRVNAVSPGIIKTPMHGEESHAALGQMHPVGHMGEVSEIAQAIIYLENAGFVTGEILHVDGGQSAGH	MNFEGKIALVTGASRGIGRAIAETLAARGAKVIGTATSENGAQAISDYLGANGKGLMLNVTDPASIESVLEKIRAEFGEVDILVNNAGITRDNLLMRMKDEEWNDIIETNLSSVFRLSKAVMRAMMKKRHGRIITIGSVVGTMGNGGQANYAAAKAGLIGFSKSLAREVASRGITVNVVAPGFIETDMTRALSDDQRAGILAQVPAGRLGGAQEIANAVAFLASDEAAYITGETLHVNGGMYMV	48.36	gnl|BL_ORD_ID|4713|hsp_num:0	2681			372	720	triclosan
AM181176.4|Pseudomonas_13 # 16273 # 16680 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.605	AM181176.4|Pseudomonas_13 	16273	16680	+	Loose	500	26.1794	OXA-512	50.0	3005742	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAACGGACTCTCTCCCTGTCCCTCGTCCTCCTCACCGCCGCTCTCGGCGCGTGCTCCACCCATCAGTCGGCCAACGACCCCGCGCTGGTTGGCACTTGGAAAGGCTTGCGCACCGAGACCGGTAAATGCCAGTTCCTGTCGTGGACCAATACCCTCAAGCCTGACGGTCGTTTCGTTATTACCTTCTACCGCGATGCGCAGCAGACGCAGGTGATCCAGACGGAGCAGGGTTCGTGGGCGGCGGCCAATGGTAAGAATGAGCTGCGCACAGATGGCGTGCGTTCGCCGGATGTGTACACCTATAAGCTGCTGGACGCAGACACTGTTCACTATGTGAGTGTGGCATCGGACCCCACCAGCGATTGCCAGGACGACTACCAGTTCACCGAGCGCCGTGTCCGCTGA	MKRTLSLSLVLLTAALGACSTHQSANDPALVGTWKGLRTETGKCQFLSWTNTLKPDGRFVITFYRDAQQTQVIQTEQGSWAAANGKNELRTDGVRSPDVYTYKLLDADTVHYVSVASDPTSDCQDDYQFTERRVR	MKLLKILSLVCLSISIGACAEHSMSRAKTSTFPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKEWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENSLYAKSGWGMAVDPQVGWYVGFVEKADGQVVAFALNMQMKAGDDSALRKQLSLDVLDKLGVFHYL	48.21	gnl|BL_ORD_ID|3777|hsp_num:0	4847			0	66	cloxacillin; oxacillin; cefalotin
AM181176.4|Pseudomonas_14 # 16638 # 17054 # 1 # ID=1_14;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.578	AM181176.4|Pseudomonas_14 	16638	17054	+	Loose	300	25.409	dfrA10	30.43	3003011	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	TTGCCAGGACGACTACCAGTTCACCGAGCGCCGTGTCCGCTGACAAGGCAGGTTTGCTTCAAAACCGGGCACTCGGGTGCCCGGCCGTCACAAGTTTCAACTCCCTTGCGCGCACGTGCCCGCACCTTTCTCGTAGTCCAATACCTGTTTTTGCCGGGCGTGAGCATCAGCAGCAAAAGCCTACAGCCTGACTGCGATCAATTTGGTCTAGTTAATGGGGCGTATCTTCCAGGCTCAGCAGGTTTAGCGCTCTGGAGGTGTCTGCCCTGTGTCATTCGGCGTGGGTTTTGCTTCGTCGTCTTGGCTGCCTGCGCAGCGATATACGGGCCGTGGCTTTGCGGGCGGTTGCGGATCGACCGCTCGGCAGTTTCGTCCTTGAATACAGGCGAGGTTTCCGTATTCTGTCGCGCGATATAA	MPGRLPVHRAPCPLTRQVCFKTGHSGARPSQVSTPLRARARTFLVVQYLFLPGVSISSKSLQPDCDQFGLVNGAYLPGSAGLALWRCLPCVIRRGFCFVVLAACAAIYGPWLCGRLRIDRSAVSSLNTGEVSVFCRAI	MNISLIFANELITRAFGNQGKLPWQFIKEDMQFFQKTTENSVVVMGLNTWRSLPKMKKLGRDFIVISSTITEHEVLNNNIQIFKSFESFLEAFRDTTKPINVIGGVGLLSEAIEHASTVYMSSIHMVKPVHADVYVPVELMNKLYSDFKYPENILWVGDPIDSVYSLSIDKFVRPASLVGVPNDINT	73.80	gnl|BL_ORD_ID|1379|hsp_num:0	1497			135	270	trimethoprim
AM181176.4|Pseudomonas_15 # 17585 # 18451 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=GAA;rbs_spacer=15bp;gc_cont=0.638	AM181176.4|Pseudomonas_15 	17585	18451	+	Loose	450	28.8758	ermZ	36.36	3004605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	TTGCTGCGTCTGTTGGAAGAGCTGAGCCAAGGCGAAGCCGACCACCTGCAGCCGCCCGAAGTGGTGGAAGGGCGGGACGGTGAGGTGTACTCGGAGCATTCCAGCCCCAACGTCGTGGTGGTTGTCTCGGTAAAAGGCGGCGTTGGCCGCAGCACCCTGACTGCCGCGATTGCCAGTGGTTTGCAGCGTCAGGGGCGCCCGGCACTGGCCCTGGACCTGGACCCGCAAAACGCCCTGCGCCACCACTTGTGCCTCGGTCTCGACATGCCCGGCGTGGGCGCGACCAGCTTGCTCAATGAAAGCTGGGAAGCGCTGCCCGAGCGCGGTTTTGCCGGGTGCCGCCTGGTGGCATTCGGTGCTACCGACCACGAGCAGCAACAGAGCCTGAATCGCTGGCTGGGCCAGGATGACGAATGGCTGAGCAAACGCTTGGCCGGCCTCAAATTGAACGGCCAGGACACCGTGATCATCGACGTCCCGGCCGGCAATACCGTGTACTTCAGCCAAGCCATGTCGGTCGCCGACGCAGTGCTGGTAGTGGTGCAGCCGGACGTGGCGTCCTTCAGCACGCTCGATCAGATGGACAGCGTGCTCAAGCCCTCTCTCAATCGCAAAAAAACGCCACGACGCTTCTATGTGATCAACCAACTGGACGGTGCCCACCGCTTCAGCCTGGACATGGCCGAGGTGTTCAAGACCCGCCTGGGTGCTGCCCTGTTGGGGACGGTCCACCGCGACCCCGCGTTCAGCGAAGCCCAGGCCTACGGGCGTGATCCCCTTGACCCCACCGTCAACAGTATCGGCAGCCAGGACATCCATGCCCTGTGCCGCGCATTGCTCGAACGAATCGACTCGGACCTCCCATGA	MLRLLEELSQGEADHLQPPEVVEGRDGEVYSEHSSPNVVVVVSVKGGVGRSTLTAAIASGLQRQGRPALALDLDPQNALRHHLCLGLDMPGVGATSLLNESWEALPERGFAGCRLVAFGATDHEQQQSLNRWLGQDDEWLSKRLAGLKLNGQDTVIIDVPAGNTVYFSQAMSVADAVLVVVQPDVASFSTLDQMDSVLKPSLNRKKTPRRFYVINQLDGAHRFSLDMAEVFKTRLGAALLGTVHRDPAFSEAQAYGRDPLDPTVNSIGSQDIHALCRALLERIDSDLP	MTLKSPLPPQSVSAPADSRSTARREWGQNFFRTAAAACRFSAQLDGSDTIPPDSPNDLMTVEIGAGSGRVTKVLASPGTPLLAVEIDPRWARRLAAESLPDVTVVNEDFLTLQLPGQPVRLIGNLPFVTGTRMLRRCLDMGPARMRQGVFLLQREYVGKRTGAWGGNLFNAQWEPWYSFDRGLAFSRQDFTPVPRADTQTLMVAPHRRPSVPWREKAAYQRFVQRVFDTGQMTVGDAARKVLRRGHAQFVRGAGVRPADRVKDLTVPEWTALFRAYGRTADR	102.13	gnl|BL_ORD_ID|225|hsp_num:0	3303			132	279	spiramycin
AM181176.4|Pseudomonas_16 # 18448 # 20667 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAAT;rbs_spacer=15bp;gc_cont=0.630	AM181176.4|Pseudomonas_16 	18448	20667	+	Loose	550	27.7202	PmrF	31.82	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCGACACTACGTCCTCCACGCCCTTCGTCGAAGGGCGCGCTGAACAGCGCCTAAATGGCGCCATCGCGCGCTTCAATCGGTGGCCTTCGGCGCCGCGTACGGTACTGGTTGTTGCCAGTTGCGTGCTCGGCGCCATGCTGCTGCTGGGCATTATCAGCGCGCCGCTCGACCTCTACAGCCAATGCCTGTTTGCCGCCGTGTGCTTCCTGGCGGTGCTGGTACTGCGCAAGATCCCGGGGCGCCTGGCGATCCTCGCCTTGGTGGTGTTGTCGCTGGTGGCGTCGTTGCGCTACATGTTCTGGCGCCTCACCTCCACCCTCGGCTTTGAAACCTGGGTCGACATGTTCTTCGGCTACGGCCTGGTCGCGGCCGAGTTCTACGCCCTGATCGTGCTGATCTTCGGCTACGTGCAAACCGCCTGGCCGCTGCGCCGCACGCCGGTGTGGCTCAAGACTGAGCCGGAAGAGTGGCCGACGGTCGACGTGTTCATCCCGACGTATAACGAGGCGCTGAGCATCGTAAAGCTGACCATTTTCGCCGCCCAGGCGATGGACTGGCCCAAGGACAAGCTGCGCGTCCACGTGCTCGACGACGGTCGCCGCGACGACTTCCGCGAATTCTGCCGCAAGGTCGGCGTGAACTACATCCGGCGCGACAATAACTTCCACGCCAAGGCCGGTAACCTCAACGAAGCGTTGAAGGTCACCGACGGCGAATACATCGCCCTGTTCGACGCCGACCACGTGCCGACGCGTTCCTTCCTGCAAGTGAGCCTGGGCTGGTTCCTGAAAGATCCGAAGCTGGCGATGCTGCAAACGCCGCACTTCTTCTTCTCGCCGGACCCGTTTGAAAAGAACCTCGACACGTTCCGCGCCGTGCCCAACGAAGGTGAGCTGTTCTACGGCCTGGTGCAGGACGGCAACGACCTGTGGAACGCCACCTTCTTCTGTGGCTCCTGTGCCGTGATTCGCCGTGAGCCGCTGCTGGAAATCGGCGGCGTAGCCGTTGAGACCGTGACCGAAGACGCCCACACCGCGCTCAAGCTCAACCGCCTGGGCTACAACACCGCTTACCTGGCCATCCCACAAGCCGCGGGCCTGGCCACTGAAAGCCTGTCGCGCCACATCAACCAGCGCATTCGCTGGGCACGGGGCATGGCGCAGATTTTCCGCACCGACAACCCGCTGCTGGGCAAAGGCCTGAAGTGGGGCCAGCGCATCTGTTATGCCAACGCCATGCTGCACTTCTTCTATGGTTTGCCGCGCCTGGTGTTTTTGACCGCGCCGTTGGCCTACCTGATTTTCGGCGCCGAAATCTTCCACGCATCGGCGCTGATGATCGTCGCCTATGTGTTGCCGCACTTGGTGCACTCCAGCCTGACCAACTCGCGGATCCAGGGGCGCTTCCGTCACTCGTTCTGGAACGAGGTGTACGAGACCGTACTGGCCTGGTACATCCTGCCGCCGGTGCTGGTCGCGCTGGTCAATCCCAAGGCGGGTGGCTTCAACGTCACCGACAAGGGCGGCATCATCGACAAGCAGTTCTTCGACTGGAAACTCGCCCGGCCCTACCTGGTGTTGTTGGCGGTCAACCTGATCGGCCTCGGCTTCGGTATCCACCAGTTGATCTGGGGCGATGCGTCCACTGCCGTGACGGTGGCGATCAACCTGACCTGGACCCTCTATAACCTGATCATCACCAGTGCCGCCGTGGCCGTGGCCTCGGAAGCACGCCAAGTGCGTTCCGAGCCGCGTGTCAGCGCCAAGCTGCCAGTGAGCATCATTTGCGCCGACGGCCGCGTGCTTGATGGCACCACCCAGGACTTCTCGCAAAACGGCTTCGGCTTGATGCTTTCCGATGGTCACTCGATCACCCAGGGTGAACGCGTGCAATTGGTACTGTCGCGCAACGGCCAGGACAGCCTGTTTGACGCCCGCGTGGTGTTCAGCAAGGGCGCGCAGATCGGCGCCCAATTCGAAGCCCTCAGCCTGCGCCAGCAAAGCGAACTGGTTCGCCTGACTTTCTCCCGCGCCGATACCTGGGCCGCGAGTTGGGGCGCCGGTCAGCCGGATACGCCGCTGGCGGCCCTGCGCGAAGTCGGCTCCATCGGCATCGGCGGCTTGTTCACCCTCGGCCGCGCCACCCTACACGAACTGCGTCTGGCCTTGAGCCGCACCCCCACAAAACCGCTAGATACGCTGATGGACAAGCCATGA	MTDTTSSTPFVEGRAEQRLNGAIARFNRWPSAPRTVLVVASCVLGAMLLLGIISAPLDLYSQCLFAAVCFLAVLVLRKIPGRLAILALVVLSLVASLRYMFWRLTSTLGFETWVDMFFGYGLVAAEFYALIVLIFGYVQTAWPLRRTPVWLKTEPEEWPTVDVFIPTYNEALSIVKLTIFAAQAMDWPKDKLRVHVLDDGRRDDFREFCRKVGVNYIRRDNNFHAKAGNLNEALKVTDGEYIALFDADHVPTRSFLQVSLGWFLKDPKLAMLQTPHFFFSPDPFEKNLDTFRAVPNEGELFYGLVQDGNDLWNATFFCGSCAVIRREPLLEIGGVAVETVTEDAHTALKLNRLGYNTAYLAIPQAAGLATESLSRHINQRIRWARGMAQIFRTDNPLLGKGLKWGQRICYANAMLHFFYGLPRLVFLTAPLAYLIFGAEIFHASALMIVAYVLPHLVHSSLTNSRIQGRFRHSFWNEVYETVLAWYILPPVLVALVNPKAGGFNVTDKGGIIDKQFFDWKLARPYLVLLAVNLIGLGFGIHQLIWGDASTAVTVAINLTWTLYNLIITSAAVAVASEARQVRSEPRVSAKLPVSIICADGRVLDGTTQDFSQNGFGLMLSDGHSITQGERVQLVLSRNGQDSLFDARVVFSKGAQIGAQFEALSLRQQSELVRLTFSRADTWAASWGAGQPDTPLAALREVGSIGIGGLFTLGRATLHELRLALSRTPTKPLDTLMDKP	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	229.50	gnl|BL_ORD_ID|1937|hsp_num:0	2014			27	159	polymyxin B
